Literature DB >> 22009832

Apoptotic effects of curcumin on human osteosarcoma U2OS cells.

Song Jin1, Hong-guang Xu, Jing-nan Shen, Xu-wu Chen, Hong Wang, Jia-guo Zhou.   

Abstract

OBJECTIVE: Curcumin, an active ingredient derived from the rhizome of the plant, Curcuma longa, has antioxidant, anti-inflammatory and anti-cancer activities. The aims of this study were to examine whether curcumin can induce apoptosis in an osteosarcoma cell line.
METHODS: Curcumin-induced apoptosis in human osteosarcoma U2OS cells was investigated using morphological analysis, marked nuclear condensation and fragmentation of chromatin, which were observed by Hoechst 33258 staining and DNA ladder formation. The U2OS cells were treated with or without curcumin. Cell viability was assessed by the 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium (MTT) method. Cell-cycle, apoptosis and apoptosis-related proteins in U2OS cells were evaluated by flow cytometry and western blotting.
RESULTS: Curcumin showed growth inhibitory effects on U2OS cells in a dose-and time-dependent manner, inducing significant G1 arrest and apoptosis in U2OS cells. This curcumin-induced apoptosis in U2OS cells was accompanied by up-regulation of Bax, Bak, and p-Bad and down-regulation of Bcl-2, but no effect on the levels of Bcl-X(L) or Bad proteins was noted. Moreover, curcumin treatment resulted in a significant reduction of mitochondrial membrane potential and increase in the concentrations of mitochondrial cytochrome C and caspase-3.
CONCLUSION: Multiple molecular pathways are involved in curcumin-induced apoptosis of human U2OS cells. These include pro-and anti-apoptotic Bcl-2 family proteins, mitochondrial membrane potential, mitochondrial cytochrome C and caspase-3.
© 2009 Tianjin Hospital and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 22009832      PMCID: PMC6583456          DOI: 10.1111/j.1757-7861.2009.00019.x

Source DB:  PubMed          Journal:  Orthop Surg        ISSN: 1757-7853            Impact factor:   2.071


  10 in total

1.  A study on screening of osteosarcoma U2OS cell inhibiting active components from nidus vespae.

Authors:  Zhenhuan Jiang; Jiannong Jiang; Qiang Wang; Leiyan Zhang; Chenguang Wu; Huilin Yang
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-10-03

Review 2.  Therapeutic actions of curcumin in bone disorders.

Authors:  Ramin Rohanizadeh; Yi Deng; Elise Verron
Journal:  Bonekey Rep       Date:  2016-03-02

3.  Selective inhibition of MG-63 osteosarcoma cell proliferation induced by curcumin-loaded self-assembled arginine-rich-RGD nanospheres.

Authors:  Run Chang; Linlin Sun; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2015-05-05

4.  Short communication: selective cytotoxicity of curcumin on osteosarcoma cells compared to healthy osteoblasts.

Authors:  Run Chang; Linlin Sun; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2014-01-10

5.  Invertible micellar polymer nanoassemblies target bone tumor cells but not normal osteoblast cells.

Authors:  Olena Kudina; Kristen L Shogren; Carl T Gustafson; Michael J Yaszemski; Avudaiappan Maran; Andriy Voronov
Journal:  Future Sci OA       Date:  2015-11-01

Review 6.  Curcumin and Osteosarcoma: Can Invertible Polymeric Micelles Help?

Authors:  Avudaiappan Maran; Michael J Yaszemski; Ananiy Kohut; Andriy Voronov
Journal:  Materials (Basel)       Date:  2016-06-27       Impact factor: 3.623

7.  Controlled temperature-mediated curcumin release from magneto-thermal nanocarriers to kill bone tumors.

Authors:  A Khodaei; F Jahanmard; H R Madaah Hosseini; R Bagheri; A Dabbagh; H Weinans; S Amin Yavari
Journal:  Bioact Mater       Date:  2021-10-05

8.  GO-Y078, a Curcumin Analog, Induces Both Apoptotic Pathways in Human Osteosarcoma Cells via Activation of JNK and p38 Signaling.

Authors:  Peace Wun-Ang Lu; Renn-Chia Lin; Jia-Sin Yang; Eric Wun-Hao Lu; Yi-Hsien Hsieh; Meng-Ying Tsai; Ko-Hsiu Lu; Shun-Fa Yang
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-24

9.  Curcumin may serve an anticancer role in human osteosarcoma cell line U-2 OS by targeting ITPR1.

Authors:  Zhanpeng Luo; Dawei Li; Xiaobo Luo; Litao Li; Suxi Gu; Long Yu; Yuanzheng Ma
Journal:  Oncol Lett       Date:  2018-02-13       Impact factor: 2.967

10.  CLEFMA Activates the Extrinsic and Intrinsic Apoptotic Processes through JNK1/2 and p38 Pathways in Human Osteosarcoma Cells.

Authors:  Jia-Sin Yang; Renn-Chia Lin; Yi-Hsien Hsieh; Heng-Hsiung Wu; Geng-Chung Li; Ya-Chiu Lin; Shun-Fa Yang; Ko-Hsiu Lu
Journal:  Molecules       Date:  2019-09-09       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.